Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

OTC safety

This article was originally published in The Tan Sheet

Executive Summary

Whitehall-Robins' Robitussin CF labeling does not indicate OTC may increase risk of lung infection and airway blockage, while Advil Cold & Sinus labeling fails to note it may reduce effectiveness of certain antihypertensive drugs, according to August Consumer Reports On Health review of OTC drug safety. Article advises consumers be cognizant of side effects, over-dosing, misdiagnosing, allergies and drug interactions, noting "nearly every OTC drug poses some risks, especially when taken too often, in high doses or with the wrong food, drinks or medications." CR notes exceeding heartburn drug dosage can cause agitation, confusion; acetaminophen overdoses can lead to liver poisoning

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS092912

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel